The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.

The metabolic syndrome. Endocr Rev (2008) 5.33

Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology (2010) 3.60

Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology (2011) 3.24

Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol (2007) 2.71

Nutritional programming of the metabolic syndrome. Nat Rev Endocrinol (2009) 2.51

PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease. Hepatology (2010) 2.35

Aging promotes the development of diet-induced murine steatohepatitis but not steatosis. Hepatology (2013) 2.32

Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J Gastroenterol (2008) 2.17

PPARalpha: energy combustion, hypolipidemia, inflammation and cancer. Nucl Recept Signal (2010) 2.08

Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia (2009) 2.03

Body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community-based retrospective longitudinal cohort study. J Gastroenterol (2012) 2.03

Nonalcoholic fatty liver disease among HIV-infected persons. J Acquir Immune Defic Syndr (2009) 1.98

NAFLD in Asia--as common and important as in the West. Nat Rev Gastroenterol Hepatol (2013) 1.90

Kidney pathological changes in metabolic syndrome: a cross-sectional study. Am J Kidney Dis (2009) 1.74

Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women. World J Gastroenterol (2012) 1.68

Effects of metformin and weight loss on serum alanine aminotransferase activity in the diabetes prevention program. Obesity (Silver Spring) (2010) 1.64

Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. World J Gastroenterol (2011) 1.48

Improvement in liver histology is associated with reduction in dyslipidemia in children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr (2015) 1.46

Association Between Endogenous Sex Hormones and Liver Fat in a Multiethnic Study of Atherosclerosis. Clin Gastroenterol Hepatol (2015) 1.45

Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment. World J Gastroenterol (2008) 1.43

Validation of endogenous reference genes for qRT-PCR analysis of human visceral adipose samples. BMC Mol Biol (2010) 1.42

Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. Ann N Y Acad Sci (2013) 1.40

Liver diseases and metabolic syndrome. J Gastroenterol (2008) 1.33

A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease. J Gastroenterol (2010) 1.32

Obesity-related metabolic dysfunction in dogs: a comparison with human metabolic syndrome. BMC Vet Res (2012) 1.31

Common genetic variations in CLOCK transcription factor are associated with nonalcoholic fatty liver disease. World J Gastroenterol (2007) 1.31

Prevalence, gender, ethnic variations, and prognosis of NASH. J Gastroenterol (2010) 1.29

Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort. Obesity (Silver Spring) (2009) 1.28

Prevalence and factors associated with liver test abnormalities among human immunodeficiency virus-infected persons. Clin Gastroenterol Hepatol (2009) 1.20

Association between nonalcoholic fatty liver disease and coronary artery calcification. Dig Dis Sci (2009) 1.19

High serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational study. PLoS One (2010) 1.19

Raised liver enzymes in newly diagnosed Type 2 diabetes are associated with weight and lipids, but not glycaemic control. Indian J Endocrinol Metab (2012) 1.17

Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compr Physiol (2013) 1.17

Parental obesity and offspring serum alanine and aspartate aminotransferase levels: the Framingham heart study. Gastroenterology (2008) 1.15

Prevalence of Non-Alcoholic Fatty Liver Disease and Its Predictors in North of Iran. Iran J Public Health (2014) 1.14

Liver and diabetes. A vicious circle. Hepatol Res (2013) 1.10

The role of metformin in the management of NAFLD. Exp Diabetes Res (2011) 1.09

KASL clinical practice guidelines: management of nonalcoholic fatty liver disease. Clin Mol Hepatol (2013) 1.08

Protective effect of alcohol consumption for fatty liver but not metabolic syndrome. World J Gastroenterol (2012) 1.08

Prevalence of metabolic syndrome and risks of abnormal serum alanine aminotransferase in Hispanics: a population-based study. PLoS One (2011) 1.07

Association of serum alanine aminotransferase and γ-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease. Korean J Hepatol (2011) 1.07

Ellagic acid attenuates high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. Eur J Nutr (2012) 1.07

Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period. J Gastroenterol (2011) 1.05

Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome. World J Gastroenterol (2012) 1.05

Multicausality in fatty liver disease: is there a rationale to distinguish between alcoholic and non-alcoholic origin? World J Gastroenterol (2012) 1.05

Serum uric Acid as a predictor for the development of nonalcoholic Fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study. Gut Liver (2010) 1.03

Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology (2014) 1.02

VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation. PLoS One (2012) 1.02

Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic. World J Gastroenterol (2014) 1.02

Association of hormonal dysregulation with metabolic syndrome in older women: data from the InCHIANTI study. Am J Physiol Endocrinol Metab (2006) 1.00

The Effect of Metformin and Standard Therapy versus Standard Therapy alone in Nondiabetic Patients with Insulin Resistance and Nonalcoholic Steatohepatitis (NASH): A Pilot Trial. Therap Adv Gastroenterol (2009) 0.99

Pioglitazone, but not metformin, reduces liver fat in Type-2 diabetes mellitus independent of weight changes. J Diabetes Complications (2009) 0.96

Clinical features of nonalcoholic steatohepatitis in Japan: Evidence from the literature. J Gastroenterol (2006) 0.94

The blind men 'see' the elephant-the many faces of fatty liver disease. World J Gastroenterol (2008) 0.94

Predictive factors for the development or regression of Fatty liver in Japanese adults. J Clin Biochem Nutr (2009) 0.93

Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011-2012. J Gastroenterol (2014) 0.93

Managing nonalcoholic fatty liver disease: recommendations for family physicians. Can Fam Physician (2007) 0.93

Nonalcoholic fatty liver disease and cardiovascular risk. Curr Gastroenterol Rep (2009) 0.93

High-sensitivity C-reactive protein as a serum predictor of nonalcoholic fatty liver disease based on the Akaike Information Criterion scoring system in the general Japanese population. J Gastroenterol (2009) 0.93

Plasma free myristic acid proportion is a predictor of nonalcoholic steatohepatitis. Dig Dis Sci (2011) 0.92

Carotid lesions in outpatients with nonalcoholic fatty liver disease. World J Gastroenterol (2009) 0.92

Prevalence of non-alcoholic fatty liver disease in children and relationship to metabolic syndrome, insulin resistance, and waist circumference. Environ Health Prev Med (2009) 0.92

AMPK-associated signaling to bridge the gap between fuel metabolism and hepatocyte viability. World J Gastroenterol (2010) 0.92

Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients. J Gastroenterol (2013) 0.92

De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose. Biol Rev Camb Philos Soc (2015) 0.91

Aminotransferase levels are associated with cardiometabolic risk above and beyond visceral fat and insulin resistance: the Framingham Heart Study. Arterioscler Thromb Vasc Biol (2012) 0.91

Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units. BMC Gastroenterol (2012) 0.91

Soluble CD14 levels reflect liver inflammation in patients with nonalcoholic steatohepatitis. PLoS One (2013) 0.90

Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort. Hepatology (2016) 0.89

Subcutaneous adipose tissue in relation to subclinical atherosclerosis and cardiometabolic risk factors in midlife women. Am J Clin Nutr (2011) 0.89

Epidemiology and Natural History of Non-alcoholic Fatty Liver Disease. J Clin Exp Hepatol (2012) 0.88

Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD. Diabetes Care (2015) 0.88

Life style modification improves insulin resistance and liver histology in patients with non-alcoholic fatty liver disease. World J Hepatol (2012) 0.88

Characteristics of chronic fatigue syndrome in a Japanese community population : chronic fatigue syndrome in Japan. Clin Rheumatol (2011) 0.88

Association between nonalcoholic fatty liver disease and the incidence of cardiovascular and renal events. J Saudi Heart Assoc (2013) 0.88

Testosterone level in men with type 2 diabetes mellitus and related metabolic effects: A review of current evidence. J Diabetes Investig (2014) 0.88

Dangerous liaisons: the metabolic syndrome and nonalcoholic fatty liver disease. Ann Intern Med (2005) 0.87

Abdominal adiposity and daily step counts as determinants of glycemic control in a cohort of patients with type 2 diabetes mellitus. Nutr Diabetes (2012) 0.87

Metabolic syndrome in rheumatoid arthritis. Mediators Inflamm (2013) 0.87

Metabolic syndrome, C-reactive protein, and mortality in U.S. Blacks and Whites: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Diabetes Care (2014) 0.87

Metabolic syndrome and chronic kidney disease: Current status and future directions. World J Nephrol (2014) 0.87

Metabolic markers and ALT cutoff level for diagnosing nonalcoholic fatty liver disease: a community-based cross-sectional study. J Gastroenterol (2012) 0.86

Sterol regulatory element-binding factor 2 (SREBF-2) predicts 7-year NAFLD incidence and severity of liver disease and lipoprotein and glucose dysmetabolism. Diabetes (2012) 0.86

Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population. BMJ Open (2015) 0.86

Impact of visceral fat on the metabolic syndrome and nonalcoholic fatty liver disease. J Korean Med Sci (2008) 0.86

Independent association of HbA1c and nonalcoholic fatty liver disease in an elderly Chinese population. BMC Gastroenterol (2013) 0.86

Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome. Int J Mol Sci (2016) 0.86

Angiotensin receptor blockade recovers hepatic UCP2 expression and aconitase and SDH activities and ameliorates hepatic oxidative damage in insulin resistant rats. Endocrinology (2012) 0.85

Hepatitis C Virus, Insulin Resistance, and Steatosis. J Clin Transl Hepatol (2016) 0.85

Metabolically healthy obesity and risk of incident CKD. Clin J Am Soc Nephrol (2015) 0.85

Ethnic and sex differences in fatty liver on cardiac computed tomography: the multi-ethnic study of atherosclerosis. Mayo Clin Proc (2014) 0.85

Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol (2013) 0.84

Increased levels of systolic blood pressure within the normal range are associated with significantly elevated risks of nonalcoholic fatty liver disease. Medicine (Baltimore) (2015) 0.84

Synergistic effect of fatty liver and smoking on metabolic syndrome. World J Gastroenterol (2009) 0.84

Development and validation of a simple index system to predict nonalcoholic fatty liver disease. Korean J Hepatol (2011) 0.84

Association between metabolic syndrome and the development of non-alcoholic fatty liver disease. Exp Ther Med (2013) 0.84

Impact of Weight Loss Surgery on Esophageal Physiology. Gastroenterol Hepatol (N Y) (2015) 0.84

Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease. World J Gastroenterol (2014) 0.83

Spinal cord injury causes chronic liver pathology in rats. J Neurotrauma (2014) 0.83

Serum alanine aminotransferase concentration as a predictive factor for the development or regression of fatty liver. J Clin Biochem Nutr (2011) 0.83

The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol (2007) 4.01

Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol (2007) 2.71

The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-gamma. Prog Neuropsychopharmacol Biol Psychiatry (2007) 2.50

Enhanced expression of long non-coding RNA HOTAIR is associated with the development of gastric cancer. PLoS One (2013) 2.26

IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J Immunol (2004) 2.12

Efficacy of intraoperative wound irrigation for preventing shunt infection. J Neurosurg Pediatr (2008) 2.02

Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women. World J Gastroenterol (2012) 1.68

Therapeutic effect of intraarterial prednisolone injection in severe intestinal Behçet's disease. J Gastroenterol (2002) 1.63

Enhanced production of monocyte chemoattractant protein-1 in the dorsal root ganglia in a rat model of neuropathic pain: possible involvement in the development of neuropathic pain. Neurosci Res (2004) 1.63

Discovery of novel and selective IKK-beta serine-threonine protein kinase inhibitors. Part 1. Bioorg Med Chem Lett (2003) 1.62

Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma. Cancer Sci (2012) 1.54

Nuclear targeting of Akt antagonizes aspects of cardiomyocyte hypertrophy. Proc Natl Acad Sci U S A (2006) 1.48

Radixin deficiency causes deafness associated with progressive degeneration of cochlear stereocilia. J Cell Biol (2004) 1.47

Cytokines and schizophrenia: Microglia hypothesis of schizophrenia. Psychiatry Clin Neurosci (2009) 1.43

Functional relation among RecQ family helicases RecQL1, RecQL5, and BLM in cell growth and sister chromatid exchange formation. Mol Cell Biol (2003) 1.43

Paracrine receptor activation by microenvironment triggers bypass survival signals and ALK inhibitor resistance in EML4-ALK lung cancer cells. Clin Cancer Res (2012) 1.42

Bloom helicase and DNA topoisomerase IIIalpha are involved in the dissolution of sister chromatids. Mol Cell Biol (2006) 1.41

Depressive state and paresthesia dramatically improved by intravenous MgSO4 in Gitelman's syndrome. Intern Med (2004) 1.38

Durable panicle blast-resistance gene Pb1 encodes an atypical CC-NBS-LRR protein and was generated by acquiring a promoter through local genome duplication. Plant J (2010) 1.35

Survival of geriatric patients after percutaneous endoscopic gastrostomy in Japan. World J Gastroenterol (2010) 1.30

Pharmacological inhibition of Notch signaling in the mature guinea pig cochlea. Neuroreport (2007) 1.27

Differential contributions of the basolateral and central nuclei of the amygdala in the negative affective component of chemical somatic and visceral pains in rats. Eur J Neurosci (2003) 1.24

Endovascular treatment strategy for direct carotid-cavernous fistulas resulting from rupture of intracavernous carotid aneurysms. AJNR Am J Neuroradiol (2003) 1.18

Novel strategy for treatment of inner ears using a biodegradable gel. Laryngoscope (2005) 1.16

Prognosis of canine patients with nasal tumors according to modified clinical stages based on computed tomography: a retrospective study. J Vet Med Sci (2008) 1.15

Gene transfer of GLT-1, a glial glutamate transporter, into the spinal cord by recombinant adenovirus attenuates inflammatory and neuropathic pain in rats. Mol Pain (2008) 1.14

Met kinase inhibitor E7050 reverses three different mechanisms of hepatocyte growth factor-induced tyrosine kinase inhibitor resistance in EGFR mutant lung cancer. Clin Cancer Res (2012) 1.12

An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro. J Pharmacol Exp Ther (2003) 1.12

Antidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxide. Exp Neurol (2007) 1.11

ERK5 is a target for gene amplification at 17p11 and promotes cell growth in hepatocellular carcinoma by regulating mitotic entry. Genes Chromosomes Cancer (2009) 1.11

Acute cold hypersensitivity characteristically induced by oxaliplatin is caused by the enhanced responsiveness of TRPA1 in mice. Mol Pain (2012) 1.11

Drug delivery to the cochlea using PLGA nanoparticles. Laryngoscope (2005) 1.10

Invasion of epithelial cells and proteolysis of cellular focal adhesion components by distinct types of Porphyromonas gingivalis fimbriae. Infect Immun (2006) 1.09

Reactive oxygen species derived from NOX1/NADPH oxidase enhance inflammatory pain. J Neurosci (2008) 1.09

Protective effect of alcohol consumption for fatty liver but not metabolic syndrome. World J Gastroenterol (2012) 1.08

Transient receptor potential canonical 3 (TRPC3) mediates thrombin-induced astrocyte activation and upregulates its own expression in cortical astrocytes. J Neurosci (2010) 1.07

Aging effects on vestibulo-ocular responses in C57BL/6 mice: comparison with alteration in auditory function. Audiol Neurootol (2005) 1.06

Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma. J Transl Med (2005) 1.06

Correlation between T2 relaxation time and intervertebral disk degeneration. Skeletal Radiol (2011) 1.06

Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry (2008) 1.05

Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome. World J Gastroenterol (2012) 1.05

A novel model for rapid induction of apoptosis in spiral ganglions of mice. Laryngoscope (2003) 1.05

EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells. Cancer Lett (2007) 1.04

Circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 are associated with early carotid atherosclerosis. Arterioscler Thromb Vasc Biol (2004) 1.04

Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Psychopharmacology (Berl) (2003) 1.03

Anti-inflammatory role of PGD2 in acute lung inflammation and therapeutic application of its signal enhancement. Proc Natl Acad Sci U S A (2013) 1.03

Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Jpn J Pharmacol (2002) 1.02

Dibutyryl cyclic AMP induces differentiation of human neuroblastoma SH-SY5Y cells into a noradrenergic phenotype. Neurosci Lett (2008) 1.02

Trophic support of mouse inner ear by neural stem cell transplantation. Neuroreport (2003) 1.01

Role of reactive radicals in degeneration of the auditory system of mice following cisplatin treatment. Acta Otolaryngol (2004) 1.01

TRPM2 contributes to inflammatory and neuropathic pain through the aggravation of pronociceptive inflammatory responses in mice. J Neurosci (2012) 1.00

Gene transfer of GLT-1, a glutamate transporter, into the nucleus accumbens shell attenuates methamphetamine- and morphine-induced conditioned place preference in rats. Eur J Neurosci (2005) 1.00

Fate of neural stem cells grafted into injured inner ears of mice. Neuroreport (2003) 1.00

Sorting nexin 27 interacts with multidrug resistance-associated protein 4 (MRP4) and mediates internalization of MRP4. J Biol Chem (2012) 0.99

Identification of human autologous cytotoxic T-lymphocyte-defined osteosarcoma gene that encodes a transcriptional regulator, papillomavirus binding factor. Cancer Res (2004) 0.99

Novel therapy for hearing loss: delivery of insulin-like growth factor 1 to the cochlea using gelatin hydrogel. Otol Neurotol (2007) 0.99

Changes in endoscopic findings of gastritis after cure of H. pylori infection: multicenter prospective trial. Dig Endosc (2012) 0.98

Metastatic renal cell carcinoma of the gallbladder. Asian J Surg (2006) 0.98

Bone marrow-derived cells expressing Iba1 are constitutively present as resident tissue macrophages in the mouse cochlea. J Neurosci Res (2008) 0.98

Prostagladin D2 is a mast cell-derived antiangiogenic factor in lung carcinoma. Proc Natl Acad Sci U S A (2011) 0.98

Kaempferol sensitizes colon cancer cells to TRAIL-induced apoptosis. Biochem Biophys Res Commun (2008) 0.97

Ligand-triggered resistance to molecular targeted drugs in lung cancer: roles of hepatocyte growth factor and epidermal growth factor receptor ligands. Cancer Sci (2012) 0.96

Activation of the beta-adrenoceptor-protein kinase A signaling pathway within the ventral bed nucleus of the stria terminalis mediates the negative affective component of pain in rats. J Neurosci (2008) 0.96

Visual and auditory hallucinations during normal use of paroxetine for treatment of major depressive disorder. J Neuropsychiatry Clin Neurosci (2011) 0.96

Transplantation of mouse induced pluripotent stem cells into the cochlea. Neuroreport (2009) 0.96

Comparative study of anti-oncogenic microRNA-145 in canine and human malignant melanoma. J Vet Med Sci (2011) 0.95

The novel phosphoinositide 3-kinase-mammalian target of rapamycin inhibitor, BEZ235, circumvents erlotinib resistance of epidermal growth factor receptor mutant lung cancer cells triggered by hepatocyte growth factor. Int J Cancer (2013) 0.95

Engraftment of embryonic stem cell-derived neurons into the cochlear modiolus. Neuroreport (2005) 0.95

Effect of gene transfer of GLT-1, a glutamate transporter, into the locus coeruleus by recombinant adenoviruses on morphine physical dependence in rats. Eur J Neurosci (2004) 0.95

Dose-volume comparison of proton radiotherapy and stereotactic body radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2010) 0.95

Microendoscopic discectomy for far lateral lumbar disk herniation: less surgical invasiveness and minimum 2-year follow-up results. J Spinal Disord Tech (2014) 0.95

TRPV1 stimulation triggers apoptotic cell death of rat cortical neurons. Biochem Biophys Res Commun (2008) 0.94

Role of EGF Receptor and Pyk2 in endothelin-1-induced ERK activation in rat cardiomyocytes. J Mol Cell Cardiol (2002) 0.94

Insulin-like growth factor 1 inhibits hair cell apoptosis and promotes the cell cycle of supporting cells by activating different downstream cascades after pharmacological hair cell injury in neonatal mice. Mol Cell Neurosci (2013) 0.94

SYT-SSX breakpoint peptide vaccines in patients with synovial sarcoma: a study from the Japanese Musculoskeletal Oncology Group. Cancer Sci (2012) 0.94

Analgesic effects of intrathecal administration of P2Y nucleotide receptor agonists UTP and UDP in normal and neuropathic pain model rats. J Pharmacol Exp Ther (2002) 0.93

(-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis. Cancer Sci (2009) 0.93

[Perioperative changes of the coagulation markers in patients undergoing hip fracture surgery]. Masui (2007) 0.93

Cochlear protection by local insulin-like growth factor-1 application using biodegradable hydrogel. Laryngoscope (2006) 0.92